AURELIA (GCIG/Roche)

Trial Description: 
A multi-centre, open-label, randomised, two-arm Phase III trial of bevacizumab plus chemotherapy versus chemotherapy alone in patients with platinum-resistant, epithelial ovarian, fallopian tube or primary peritoneal cancer
Lead Cooperative Group: 
Disease Site: 
Ovarian
Trial Status: 
Completed
Contact person: